Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 13 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Balaji Amines Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 13, 2025, 4:20 pm

Market Cap 3,912 Cr.
Current Price 1,208
High / Low 2,550/1,206
Stock P/E21.3
Book Value 546
Dividend Yield0.90 %
ROCE16.8 %
ROE12.5 %
Face Value 2.00
PEG Ratio-4.37

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Balaji Amines Ltd

Competitors of Balaji Amines Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Gujchem Distillers India Ltd 111 Cr. 310 541/73.0 3900.00 %1.38 %2.17 % 1.00
Elantas Beck India Ltd 7,471 Cr. 9,424 14,980/7,60153.5 1,0940.05 %23.0 %17.4 % 10.0
Crestchem Ltd 75.8 Cr. 253 350/10727.3 21.10.20 %78.2 %56.2 % 10.0
Chemiesynth (Vapi) Ltd 11.0 Cr. 35.8 34.1/0.00 37.50.00 %1.00 %3.38 % 10.0
Archit Organosys Ltd 88.2 Cr. 43.0 61.0/34.240.3 32.20.00 %3.69 %0.75 % 10.0
Industry Average4,667.50 Cr1,549.2453.73325.780.33%15.97%12.07%7.41

All Competitor Stocks of Balaji Amines Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 565780670628586471464381383414385347313
Expenses 410584455455458378366327309316319286267
Operating Profit 1551962151731289398547498666146
OPM % 27%25%32%27%22%20%21%14%19%24%17%17%15%
Other Income 4553366789898
Interest 4732332221111
Depreciation 10111111121111111112121212
Profit before tax 1451832051621158590487093625741
Tax % 30%29%28%27%27%35%25%24%21%22%26%27%24%
Net Profit 102131148119845568365672464131
EPS in Rs 27.6433.5537.9528.5719.3114.6316.2710.7115.2421.0013.3612.6510.24

Last Updated: February 28, 2025, 8:30 pm

Below is a detailed analysis of the quarterly data for Balaji Amines Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹313.00 Cr.. The value appears to be declining and may need further review. It has decreased from 347.00 Cr. (Sep 2024) to ₹313.00 Cr., marking a decrease of 34.00 Cr..
  • For Expenses, as of Dec 2024, the value is ₹267.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 286.00 Cr. (Sep 2024) to ₹267.00 Cr., marking a decrease of 19.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 61.00 Cr. (Sep 2024) to ₹46.00 Cr., marking a decrease of 15.00 Cr..
  • For OPM %, as of Dec 2024, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Sep 2024) to 15.00%, marking a decrease of 2.00%.
  • For Other Income, as of Dec 2024, the value is ₹8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to ₹8.00 Cr., marking a decrease of 1.00 Cr..
  • For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹12.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 12.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Sep 2024) to ₹41.00 Cr., marking a decrease of 16.00 Cr..
  • For Tax %, as of Dec 2024, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Sep 2024) to 24.00%, marking a decrease of 3.00%.
  • For Net Profit, as of Dec 2024, the value is ₹31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Sep 2024) to ₹31.00 Cr., marking a decrease of 10.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 10.24. The value appears to be declining and may need further review. It has decreased from ₹12.65 (Sep 2024) to 10.24, marking a decrease of ₹2.41.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:08 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 5096086166406688589409351,3082,3142,3461,6341,458
Expenses 4295175155145196767477549351,6911,7361,3101,188
Operating Profit 8091102127149182193181373623609324270
OPM % 16%15%17%20%22%21%21%19%29%27%26%20%19%
Other Income 434391245615153034
Interest 25323522139132318171264
Depreciation 13162019201920323442464548
Profit before tax 46465188126166165131327578567302252
Tax % 32%27%35%34%34%32%29%26%25%28%28%23%
Net Profit 313433588211311797243418406232191
EPS in Rs 9.6210.3410.2517.7825.4234.9336.2732.3473.51113.71100.4763.2257.25
Dividend Payout % 14%10%12%11%9%7%8%10%5%5%10%17%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)9.68%-2.94%75.76%41.38%37.80%3.54%-17.09%150.52%72.02%-2.87%-42.86%
Change in YoY Net Profit Growth (%)0.00%-12.62%78.70%-34.38%-3.57%-34.27%-20.63%167.61%-78.50%-74.89%-39.99%

Balaji Amines Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:10%
5 Years:12%
3 Years:8%
TTM:-14%
Compounded Profit Growth
10 Years:20%
5 Years:12%
3 Years:-5%
TTM:0%
Stock Price CAGR
10 Years:30%
5 Years:32%
3 Years:-25%
1 Year:-41%
Return on Equity
10 Years:23%
5 Years:22%
3 Years:22%
Last Year:12%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:56 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 6666666666666
Reserves 1651952212743564615686528881,2431,5481,7151,764
Borrowings 209262256173105152227260127101582015
Other Liabilities 139158139152168229244195289395351405368
Total Liabilities 5196206236056358481,0461,1131,3101,7451,9632,1462,153
Fixed Assets 234325341341325316320573543681780896887
CWIP 6383162512326946173141113205283
Investments 20200000048007300
Other Assets 2022672782482844094574465949239961,046983
Total Assets 5196206236056358481,0461,1131,3101,7451,9632,1462,153

Below is a detailed analysis of the balance sheet data for Balaji Amines Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹6.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹1,764.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,715.00 Cr. (Mar 2024) to ₹1,764.00 Cr., marking an increase of 49.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹20.00 Cr. (Mar 2024) to ₹15.00 Cr., marking a decrease of 5.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹368.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹405.00 Cr. (Mar 2024) to ₹368.00 Cr., marking a decrease of 37.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹2,153.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,146.00 Cr. (Mar 2024) to ₹2,153.00 Cr., marking an increase of 7.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹887.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹896.00 Cr. (Mar 2024) to ₹887.00 Cr., marking a decrease of 9.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹283.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹205.00 Cr. (Mar 2024) to ₹283.00 Cr., marking an increase of 78.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹983.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,046.00 Cr. (Mar 2024) to ₹983.00 Cr., marking a decrease of 63.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹2,153.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,146.00 Cr. (Mar 2024) to ₹2,153.00 Cr., marking an increase of 7.00 Cr..

Notably, the Reserves (₹1,764.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +9411156856014094144110220354224
Cash from Investing Activity +-86-50-4-29-10-135-119-130-62-147-210-164
Cash from Financing Activity +-10-53-55-54-551621-26-37-57-81-75
Net Cash Flow-27-32-521-4-12111663-15

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-129.00-171.00-154.00-46.0044.0030.00-34.00-79.00246.00522.00551.00304.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days747971716873658185935971
Inventory Days6687114801067011677646689116
Days Payable428348585556604244541831
Cash Conversion Cycle99831369311987120116104105129156
Working Capital Days75679570787489102919494116
ROCE %19%18%18%23%30%32%24%18%35%49%36%17%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters53.70%53.70%53.70%53.70%53.71%53.71%53.71%53.71%53.71%53.71%53.71%53.71%
FIIs3.99%4.51%4.55%4.39%4.45%4.55%4.52%4.58%4.92%5.05%5.27%5.16%
DIIs0.16%0.18%0.24%0.37%0.34%0.18%0.90%1.43%1.48%1.59%1.79%1.66%
Public42.15%41.61%41.51%41.53%41.50%41.57%40.88%40.31%39.91%39.67%39.23%39.46%
No. of Shareholders1,21,0441,19,6511,20,7851,29,7021,36,6441,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,361

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Nifty Smallcap 250 Index Fund5,9250.191.2952025-03-11118400%
Motilal Oswal Nifty Smallcap 250 Index Fund3,7230.190.8152025-03-1174360%
SBI Nifty Smallcap 250 Index Fund2,7060.190.5952025-03-1154020%
ICICI Prudential Nifty Smallcap 250 Index Fund1,4680.190.3252025-03-1129260%
HDFC NIFTY Smallcap 250 ETF6710.190.1552025-03-1113320%
HDFC Nifty Smallcap 250 Index Fund5200.190.1152025-03-1110300%
Motilal Oswal Nifty 500 Index Fund4160.020.0952025-03-118220%
Edelweiss Nifty Smallcap 250 Index Fund1150.180.0352025-03-112200%
ICICI Prudential S&P BSE 500 ETF970.020.0252025-03-111840%
HDFC S&P BSE 500 ETF50.02052025-03-110%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 63.22100.47113.7173.5132.34
Diluted EPS (Rs.) 63.22100.47113.7173.5132.34
Cash EPS (Rs.) 85.70139.27141.9485.7739.84
Book Value[Excl.RevalReserv]/Share (Rs.) 584.32524.11405.81280.83206.28
Book Value[Incl.RevalReserv]/Share (Rs.) 584.32524.11405.81280.83206.28
Revenue From Operations / Share (Rs.) 506.62726.95716.14404.76288.81
PBDIT / Share (Rs.) 109.06192.70196.72117.0657.33
PBIT / Share (Rs.) 95.06178.63183.76106.4447.57
PBT / Share (Rs.) 93.07174.94178.48100.8040.46
Net Profit / Share (Rs.) 71.70125.21128.9875.1530.08
NP After MI And SOA / Share (Rs.) 63.22100.47113.7173.5132.34
PBDIT Margin (%) 21.5226.5027.4628.9219.85
PBIT Margin (%) 18.7624.5725.6526.2916.47
PBT Margin (%) 18.3724.0624.9224.9014.01
Net Profit Margin (%) 14.1517.2218.0118.5610.41
NP After MI And SOA Margin (%) 12.4713.8215.8718.1611.19
Return on Networth / Equity (%) 11.8920.9429.4726.6315.92
Return on Capital Employeed (%) 15.4131.9140.8732.3018.16
Return On Assets (%) 9.5416.5819.6518.179.41
Long Term Debt / Equity (X) 0.010.010.040.090.18
Total Debt / Equity (X) 0.010.030.050.110.36
Asset Turnover Ratio (%) 0.791.231.271.020.85
Current Ratio (X) 6.706.922.492.381.74
Quick Ratio (X) 4.784.891.961.921.33
Inventory Turnover Ratio (X) 3.114.807.205.983.76
Dividend Payout Ratio (NP) (%) 15.815.973.510.818.03
Dividend Payout Ratio (CP) (%) 12.945.233.150.716.17
Earning Retention Ratio (%) 84.1994.0396.4999.1991.97
Cash Earning Retention Ratio (%) 87.0694.7796.8599.2993.83
Interest Coverage Ratio (X) 54.8552.1537.2720.748.06
Interest Coverage Ratio (Post Tax) (X) 37.0634.8925.4414.315.23
Enterprise Value (Cr.) 6473.736259.559490.085807.491055.90
EV / Net Operating Revenue (X) 3.942.664.094.431.13
EV / EBITDA (X) 18.3210.0314.8915.315.68
MarketCap / Net Operating Revenue (X) 4.032.674.054.360.86
Retention Ratios (%) 84.1894.0296.4899.1891.96
Price / BV (X) 3.854.057.526.391.24
Price / Net Operating Revenue (X) 4.032.674.054.360.86
EarningsYield 0.030.050.030.040.12

After reviewing the key financial ratios for Balaji Amines Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
  • For Cash EPS (Rs.), as of Mar 24, the value is 85.70. This value is within the healthy range. It has decreased from 139.27 (Mar 23) to 85.70, marking a decrease of 53.57.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 584.32. It has increased from 524.11 (Mar 23) to 584.32, marking an increase of 60.21.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 584.32. It has increased from 524.11 (Mar 23) to 584.32, marking an increase of 60.21.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 506.62. It has decreased from 726.95 (Mar 23) to 506.62, marking a decrease of 220.33.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 109.06. This value is within the healthy range. It has decreased from 192.70 (Mar 23) to 109.06, marking a decrease of 83.64.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 95.06. This value is within the healthy range. It has decreased from 178.63 (Mar 23) to 95.06, marking a decrease of 83.57.
  • For PBT / Share (Rs.), as of Mar 24, the value is 93.07. This value is within the healthy range. It has decreased from 174.94 (Mar 23) to 93.07, marking a decrease of 81.87.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 71.70. This value is within the healthy range. It has decreased from 125.21 (Mar 23) to 71.70, marking a decrease of 53.51.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 63.22. This value is within the healthy range. It has decreased from 100.47 (Mar 23) to 63.22, marking a decrease of 37.25.
  • For PBDIT Margin (%), as of Mar 24, the value is 21.52. This value is within the healthy range. It has decreased from 26.50 (Mar 23) to 21.52, marking a decrease of 4.98.
  • For PBIT Margin (%), as of Mar 24, the value is 18.76. This value is within the healthy range. It has decreased from 24.57 (Mar 23) to 18.76, marking a decrease of 5.81.
  • For PBT Margin (%), as of Mar 24, the value is 18.37. This value is within the healthy range. It has decreased from 24.06 (Mar 23) to 18.37, marking a decrease of 5.69.
  • For Net Profit Margin (%), as of Mar 24, the value is 14.15. This value exceeds the healthy maximum of 10. It has decreased from 17.22 (Mar 23) to 14.15, marking a decrease of 3.07.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.47. This value is within the healthy range. It has decreased from 13.82 (Mar 23) to 12.47, marking a decrease of 1.35.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 11.89. This value is below the healthy minimum of 15. It has decreased from 20.94 (Mar 23) to 11.89, marking a decrease of 9.05.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 15.41. This value is within the healthy range. It has decreased from 31.91 (Mar 23) to 15.41, marking a decrease of 16.50.
  • For Return On Assets (%), as of Mar 24, the value is 9.54. This value is within the healthy range. It has decreased from 16.58 (Mar 23) to 9.54, marking a decrease of 7.04.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.01. This value is within the healthy range. It has decreased from 0.03 (Mar 23) to 0.01, marking a decrease of 0.02.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.79. It has decreased from 1.23 (Mar 23) to 0.79, marking a decrease of 0.44.
  • For Current Ratio (X), as of Mar 24, the value is 6.70. This value exceeds the healthy maximum of 3. It has decreased from 6.92 (Mar 23) to 6.70, marking a decrease of 0.22.
  • For Quick Ratio (X), as of Mar 24, the value is 4.78. This value exceeds the healthy maximum of 2. It has decreased from 4.89 (Mar 23) to 4.78, marking a decrease of 0.11.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.11. This value is below the healthy minimum of 4. It has decreased from 4.80 (Mar 23) to 3.11, marking a decrease of 1.69.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 15.81. This value is below the healthy minimum of 20. It has increased from 5.97 (Mar 23) to 15.81, marking an increase of 9.84.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 12.94. This value is below the healthy minimum of 20. It has increased from 5.23 (Mar 23) to 12.94, marking an increase of 7.71.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 84.19. This value exceeds the healthy maximum of 70. It has decreased from 94.03 (Mar 23) to 84.19, marking a decrease of 9.84.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 87.06. This value exceeds the healthy maximum of 70. It has decreased from 94.77 (Mar 23) to 87.06, marking a decrease of 7.71.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 54.85. This value is within the healthy range. It has increased from 52.15 (Mar 23) to 54.85, marking an increase of 2.70.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 37.06. This value is within the healthy range. It has increased from 34.89 (Mar 23) to 37.06, marking an increase of 2.17.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 6,473.73. It has increased from 6,259.55 (Mar 23) to 6,473.73, marking an increase of 214.18.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.94. This value exceeds the healthy maximum of 3. It has increased from 2.66 (Mar 23) to 3.94, marking an increase of 1.28.
  • For EV / EBITDA (X), as of Mar 24, the value is 18.32. This value exceeds the healthy maximum of 15. It has increased from 10.03 (Mar 23) to 18.32, marking an increase of 8.29.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 2.67 (Mar 23) to 4.03, marking an increase of 1.36.
  • For Retention Ratios (%), as of Mar 24, the value is 84.18. This value exceeds the healthy maximum of 70. It has decreased from 94.02 (Mar 23) to 84.18, marking a decrease of 9.84.
  • For Price / BV (X), as of Mar 24, the value is 3.85. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 23) to 3.85, marking a decrease of 0.20.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 2.67 (Mar 23) to 4.03, marking an increase of 1.36.
  • For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Balaji Amines Ltd as of March 13, 2025 is: ₹1,173.45

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 13, 2025, Balaji Amines Ltd is Overvalued by 2.86% compared to the current share price 1,208.00

Intrinsic Value of Balaji Amines Ltd as of March 13, 2025 is: 1,116.22

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 13, 2025, Balaji Amines Ltd is Overvalued by 7.60% compared to the current share price 1,208.00

Last 5 Year EPS CAGR: -4.88%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 26.58%, which is a positive sign.
  2. The company has higher reserves (773.08 cr) compared to borrowings (151.15 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (444.69 cr) and profit (218.85 cr) over the years.
  1. The stock has a high average Working Capital Days of 87.08, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 112.25, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balaji Amines Ltd:
    1. Net Profit Margin: 14.15%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 15.41% (Industry Average ROCE: 15.97%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 11.89% (Industry Average ROE: 12.07%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 37.06
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 4.78
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 21.3 (Industry average Stock P/E: 41.09)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Balaji Amines Ltd. is a Public Limited Listed company incorporated on 27/10/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24132MH1988PLC049387 and registration number is 049387. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1337.84 Cr. and Equity Capital is Rs. 6.48 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Chemicals - Organic - OthersBalaji Towers, No. 9/1/A/1, Solapur Maharashtra 413224cs@balajiamines.com
http://www.balajiamines.com
Management
NamePosition Held
Mr. A Prathap ReddyExecutive Chairman
Mr. D Ram ReddyManaging Director
Mr. A Srinivas ReddyWholeTime Director & CFO
Mr. N Rajeshwar ReddyWhole Time Director
Mr. Mohan Kumar RamakrishnaIndependent Director
Mr. Adabala Seshagiri RaoIndependent Director
Dr. Suhasini Yatin ShahIndependent Director
Dr. Uma Rajiv PradhanIndependent Director

FAQ

What is the latest intrinsic value of Balaji Amines Ltd?

The latest intrinsic value of Balaji Amines Ltd as on 13 March 2025 is 1173.45, which is 2.86% lower than the current market price of ₹1,208.00, indicating the stock is overvalued by 2.86%. The intrinsic value of Balaji Amines Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹3,912 Cr. and recorded a high/low of ₹2,550/1,206 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹1,764 Cr and total liabilities of ₹2,153 Cr.

What is the Market Cap of Balaji Amines Ltd?

The Market Cap of Balaji Amines Ltd is 3,912 Cr..

What is the current Stock Price of Balaji Amines Ltd as on 13 March 2025?

The current stock price of Balaji Amines Ltd as on 13 March 2025 is ₹1,208.

What is the High / Low of Balaji Amines Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Balaji Amines Ltd stocks is ₹2,550/1,206.

What is the Stock P/E of Balaji Amines Ltd?

The Stock P/E of Balaji Amines Ltd is 21.3.

What is the Book Value of Balaji Amines Ltd?

The Book Value of Balaji Amines Ltd is 546.

What is the Dividend Yield of Balaji Amines Ltd?

The Dividend Yield of Balaji Amines Ltd is 0.90 %.

What is the ROCE of Balaji Amines Ltd?

The ROCE of Balaji Amines Ltd is 16.8 %.

What is the ROE of Balaji Amines Ltd?

The ROE of Balaji Amines Ltd is 12.5 %.

What is the Face Value of Balaji Amines Ltd?

The Face Value of Balaji Amines Ltd is 2.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Balaji Amines Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE